{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:32:39Z","timestamp":1782977559985,"version":"3.54.5"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T00:00:00Z","timestamp":1444348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Above and Beyond, LLC"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.nbd.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T22:30:55Z","timestamp":1445034655000},"page":"11-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["\u03b2 2 -Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)"],"prefix":"10.1016","volume":"85","author":[{"given":"Raymond T.","family":"Bartus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-2072","authenticated-orcid":false,"given":"Alexandre","family":"B\u00e9tourn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Boulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.10.006_bb0005","series-title":"Adult Acid Maltase Deficiency: an Open Trial with Albuterol and Branched \u2014 Chain Aminoacids Basic Appl Myol","first-page":"71","volume":"14","author":"Angelini","year":"2004"},{"key":"10.1016\/j.nbd.2015.10.006_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-8993(78)90288-3","article-title":"Direct mapping of beta-adrenergic receptors in the rat central nervous system by a novel fluorescent beta-blocker","volume":"150","author":"Atlas","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.10.006_bb0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/107385849700300513","article-title":"The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway","volume":"3","author":"Bartus","year":"1997","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nbd.2015.10.006_bb0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","article-title":"Congenital endplate acetylcholinesterase deficiency responsive to ephedrine","volume":"65","author":"Bestue-Cardiel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s003950170003","article-title":"Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart","volume":"96","author":"Brodde","year":"2001","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2012.11.004","article-title":"Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations","volume":"23","author":"Burke","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2015.10.006_bb0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/187152707783399193","article-title":"Microglia\u2013neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems","volume":"6","author":"Carnevale","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2015.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.ijo.0801039","article-title":"The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle","volume":"23","author":"Chamberlain","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.nbd.2015.10.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084095","article-title":"Dose-effects of aorta-infused clenbuterol on spinal cord ischemia-reperfusion injury in rabbits","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.10.006_bb0050","doi-asserted-by":"crossref","first-page":"21401","DOI":"10.1073\/pnas.0909131106","article-title":"The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle","volume":"106","author":"Chinsomboon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.10.006_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0197-0186(95)00139-5","article-title":"Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone","volume":"29","author":"Colton","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2015.10.006_bb0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1471-4159.2010.06622.x","article-title":"Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity","volume":"113","author":"Counts","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.10.006_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in ALS","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0197-0186(99)00032-7","article-title":"NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study","volume":"35","author":"Culmsee","year":"1999","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2015.10.006_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2007.07.066","article-title":"Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia","volume":"575","author":"Culmsee","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2013.05.024","article-title":"Formoterol, a long-acting beta2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome","volume":"75","author":"Dang","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2015.10.006_bb0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuropharm.2013.09.027","article-title":"Noradrenaline acting on astrocytic beta(2)-adrenoceptors induces neurite outgrowth in primary cortical neurons","volume":"77","author":"Day","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0090","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.53.8.1628","article-title":"Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors","volume":"53","author":"De Keyser","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-1-9","article-title":"Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production","volume":"1","author":"Dello Russo","year":"2004","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2015.10.006_bb0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","article-title":"Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models","volume":"9","author":"Dupuis","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve\u2014an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2015.10.006_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2125.1989.tb05332.x","article-title":"Beta-adrenoceptors and human skeletal muscle characterisation of receptor subtype and effect of age","volume":"27","author":"Elfellah","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp-2012-304716","article-title":"Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1","volume":"84","author":"Finlayson","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2015.10.006_bb0120","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/01.WNL.0000118530.71646.0F","article-title":"Pilot trial of albuterol in Duchenne and Becker muscular dystrophy","volume":"62","author":"Fowler","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2008.12.003","article-title":"Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS","volume":"33","author":"Franz","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.10.006_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(98)00003-2","article-title":"Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor","volume":"242","author":"Fujita","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.10.006_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nmd.2013.08.002","article-title":"Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK","volume":"24","author":"Gallenmuller","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2015.10.006_bb0140","doi-asserted-by":"crossref","first-page":"29662","DOI":"10.1074\/jbc.M203256200","article-title":"Norepinephrine increases I kappa B alpha expression in astrocytes","volume":"277","author":"Gavrilyuk","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.10.006_bb0145","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1523\/JNEUROSCI.4175-04.2005","article-title":"Beta-adrenergic receptor activation facilitates induction of a protein synthesis-dependent late phase of long-term potentiation","volume":"25","author":"Gelinas","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.10.006_bb0150","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.molcel.2011.12.005","article-title":"The cAMP\/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+)","volume":"44","author":"Gerhart-Hines","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2015.10.006_bb0155","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1007\/s00018-011-0757-8","article-title":"Cyclic AMP: a selective modulator of NF-kappaB action","volume":"68","author":"Gerlo","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2015.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.bbi.2010.06.015","article-title":"The beta2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity","volume":"24","author":"Gleeson","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2015.10.006_bb0165","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1152\/ajpendo.00188.2011","article-title":"Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt","volume":"302","author":"Goncalves","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2015.10.006_bb0170","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00520-013-2081-3","article-title":"Phase I\/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy","volume":"22","author":"Greig","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.nbd.2015.10.006_bb0175","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0773.1995.tb00166.x","article-title":"Different beta-adrenergic receptor density in different rat skeletal muscle fibre types","volume":"76","author":"Jensen","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0180","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1681\/ASN.2013090952","article-title":"Formoterol restores mitochondrial and renal function after ischemia-reperfusion injury","volume":"25","author":"Jesinkey","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0185","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1124\/jpet.114.217380","article-title":"Atomoxetine prevents dexamethasone-induced skeletal muscle atrophy in mice","volume":"351","author":"Jesinkey","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2015.10.006_bb0190","article-title":"Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy","author":"Jiang","year":"2011","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.nbd.2015.10.006_bb0195","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.biocel.2013.06.025","article-title":"Beta2-adrenergic agonists and the treatment of skeletal muscle wasting disorders","volume":"45","author":"Joassard","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/syn.890100306","article-title":"Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics","volume":"10","author":"Joyce","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2015.10.006_bb0205","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.10.006_bb0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archneurol.2010.222","article-title":"A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis","volume":"67","author":"Khoury","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0215","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1253\/circj.69.1144","article-title":"Myocardial infarction in a 17-year-old body builder using clenbuterol","volume":"69","author":"Kierzkowska","year":"2005","journal-title":"Circ. J."},{"key":"10.1016\/j.nbd.2015.10.006_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-5728(94)90079-5","article-title":"The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats","volume":"51","author":"Kim","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0225","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/0006-2952(91)90516-8","article-title":"Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles","volume":"42","author":"Kim","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0230","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1189\/jlb.1105625","article-title":"It takes nerve to tell T and B cells what to do","volume":"79","author":"Kin","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","article-title":"Pilot trial of albuterol in spinal muscular atrophy","volume":"59","author":"Kinali","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0240","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.50.5.1402","article-title":"Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group","volume":"50","author":"Kissel","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0245","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","article-title":"Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy","volume":"57","author":"Kissel","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0250","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1152\/japplphysiol.00873.2006","article-title":"Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol","volume":"102","author":"Kline","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0255","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1113\/jphysiol.2010.196725","article-title":"Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice","volume":"588","author":"Koopman","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0260","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0265","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ijo.2012.90","article-title":"Formoterol, a highly beta2-selective agonist, increases energy expenditure and fat utilisation in men","volume":"37","author":"Lee","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.nbd.2015.10.006_bb0270","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.brainres.2007.09.034","article-title":"Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS","volume":"1185","author":"Lepore","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.10.006_bb0275","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia","volume":"44","author":"Liewluck","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2015.10.006_bb0280","first-page":"E795","article-title":"Characterization of beta-adrenergic receptors of human skeletal muscle obtained by needle biopsy","volume":"254","author":"Liggett","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0285","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1398-9995.1989.tb01068.x","article-title":"Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration","volume":"44","author":"Lofdahl","year":"1989","journal-title":"Allergy."},{"key":"10.1016\/j.nbd.2015.10.006_bb0290","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jns.2013.05.017","article-title":"Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation","volume":"331","author":"Lorenzoni","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2015.10.006_bb0295","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1152\/physrev.00028.2007","article-title":"Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease","volume":"88","author":"Lynch","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2015.10.006_bb0300","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1440-1681.1999.03001.x","article-title":"Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles","volume":"26","author":"Lynch","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0305","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jnr.20481","article-title":"Norepinephrine protects cortical neurons against microglial-induced cell death","volume":"81","author":"Madrigal","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2015.10.006_bb0310","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/ars.2006.8.885","article-title":"Effects of noradrenaline on neuronal NOS2 expression and viability","volume":"8","author":"Madrigal","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2015.10.006_bb0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0165-5728(01)00322-8","article-title":"Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis","volume":"117","author":"Makhlouf","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0320","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/cs0840651","article-title":"Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients","volume":"84","author":"Maltin","year":"1993","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.nbd.2015.10.006_bb0325","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1212\/WNL.38.9.1464","article-title":"Alterations in receptors for thyrotropin-releasing hormone, serotonin, and acetylcholine in amyotrophic lateral sclerosis","volume":"38","author":"Manaker","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0330","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1523\/JNEUROSCI.15-01-00152.1995","article-title":"Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human","volume":"15","author":"Mantyh","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.10.006_bb0335","doi-asserted-by":"crossref","first-page":"9947","DOI":"10.1073\/pnas.1309426111","article-title":"Beta2-adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome","volume":"111","author":"Mellios","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.10.006_bb0340","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nbd.2015.10.006_bb0345","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.10.006_bb0350","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2739\/kurumemedj.51.175","article-title":"Immunocytochemical localization of beta2-adrenergic receptors in the rat spinal cord and their spatial relationships to tyrosine hydroxylase-immunoreactive terminals","volume":"51","author":"Mizukami","year":"2004","journal-title":"Kurume Med. J."},{"key":"10.1016\/j.nbd.2015.10.006_bb0355","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0028-3908(02)00211-3","article-title":"Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors","volume":"43","author":"Mori","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0360","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0003-9993(99)90027-8","article-title":"Salbutamol effect in spinal cord injured individuals undergoing functional electrical stimulation training","volume":"80","author":"Murphy","year":"1999","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.nbd.2015.10.006_bb0365","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.1152\/ajpendo.2001.281.3.E449","article-title":"Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP","volume":"281","author":"Navegantes","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2015.10.006_bb9000","first-page":"380","article-title":"Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J","volume":"7","author":"Nicaise","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.nbd.2015.10.006_bb0370","first-page":"698","article-title":"Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies","volume":"41","author":"Oya","year":"2001","journal-title":"Rinsho Shinkeigaku=Clin. Neurol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0375","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1038\/srep08580","article-title":"Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records","volume":"5","author":"Paik","year":"2015","journal-title":"Sci. Report."},{"key":"10.1016\/j.nbd.2015.10.006_bb0380","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","article-title":"Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity","volume":"16","author":"Palazzolo","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.10.006_bb0385","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.nmd.2008.05.004","article-title":"Daily salbutamol in young patients with SMA type II","volume":"18","author":"Pane","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2015.10.006_bb0390","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI119674","article-title":"Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12","volume":"100","author":"Panina-Bordignon","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2015.10.006_bb0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(87)90554-4","article-title":"Autoradiographic evidence for beta-adrenergic receptors on capsaicin-sensitive primary afferent terminals in rat spinal cord","volume":"78","author":"Patterson","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.10.006_bb0400","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.apmr.2008.12.027","article-title":"Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial","volume":"90","author":"Payan","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.nbd.2015.10.006_bb0405","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/1471-2164-10-448","article-title":"Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm","volume":"10","author":"Pearen","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.nbd.2015.10.006_bb0410","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1016\/j.bmcl.2013.07.052","article-title":"Beta2-adrenoceptor agonists in the regulation of mitochondrial biogenesis","volume":"23","author":"Peterson","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2015.10.006_bb0415","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-8993(01)02174-6","article-title":"Beta-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia","volume":"899","author":"Prinz","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.10.006_bb0420","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.1002449","article-title":"Beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway","volume":"186","author":"Qian","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0425","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1212\/WNL.0b013e318295d766","article-title":"Pilot trial of clenbuterol in spinal and bulbar muscular atrophy","volume":"80","author":"Querin","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0430","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0026-895X(25)08785-1","article-title":"Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor","volume":"49","author":"Riva","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0435","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0440","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.10561","article-title":"Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials","volume":"53","author":"Rothstein","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0445","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.10.006_bb0450","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1523\/JNEUROSCI.17-14-05573.1997","article-title":"Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients","volume":"17","author":"Russo-Neustadt","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.10.006_bb0455","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharmthera.2008.06.003","article-title":"The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting","volume":"120","author":"Ryall","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2015.10.006_bb0460","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjp.0706669","article-title":"Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses","volume":"147","author":"Ryall","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0465","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuint.2013.07.006","article-title":"Stimulation of central beta2-adrenoceptors suppresses NFkappaB activity in rat brain: a role for IkappaB","volume":"63","author":"Ryan","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2015.10.006_bb0470","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.22153","article-title":"Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations","volume":"44","author":"Sadeh","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2015.10.006_bb0475","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.nmd.2009.09.008","article-title":"Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations","volume":"19","author":"Schara","year":"2009","journal-title":"Neuromuscul. Disord."},{"issue":"Suppl 3","key":"10.1016\/j.nbd.2015.10.006_bb0480","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1007\/s10545-010-9085-7","article-title":"Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction","volume":"33","author":"Schreuder","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2015.10.006_bb0485","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.2527\/jas.2006-073","article-title":"Effect of anabolic agents on calpastatin promoters in porcine skeletal muscle and their responsiveness to cyclic adenosine monophosphate- and calcium-related stimuli","volume":"84","author":"Sensky","year":"2006","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.nbd.2015.10.006_bb0490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0003-9993(95)80043-3","article-title":"Increased muscle strength in paralyzed patients after spinal cord injury: effect of beta-2 adrenergic agonist","volume":"76","author":"Signorile","year":"1995","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.nbd.2015.10.006_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100281","article-title":"Effects of chronic administration of clenbuterol on contractile properties and calcium homeostasis in rat extensor digitorum longus muscle","volume":"9","author":"Sirvent","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.10.006_bb0500","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1212\/01.WNL.0000287070.00149.a9","article-title":"Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy","volume":"70","author":"Skura","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0505","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2008.09.033","article-title":"Terbutaline in myasthenia gravis: a pilot study","volume":"277","author":"Soliven","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2015.10.006_bb0510","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/14660820600600558","article-title":"A pilot trial with clenbuterol in amyotrophic lateral sclerosis","volume":"7","author":"Soraru","year":"2006","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2015.10.006_bb0515","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0361-9230(92)90057-5","article-title":"Resting and reactive astrocytes express adrenergic receptors in the adult rat brain","volume":"29","author":"Sutin","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2015.10.006_bb0520","doi-asserted-by":"crossref","first-page":"A41","DOI":"10.1136\/adc.2011.212563.91","article-title":"Oral salbutamol in 2 wheelchair bound cases of SMA type II","volume":"96","author":"Tan","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.nbd.2015.10.006_bb0525","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jnr.10399","article-title":"Existence of functional beta1- and beta2-adrenergic receptors on microglia","volume":"70","author":"Tanaka","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2015.10.006_bb0530","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2005.12.007","article-title":"Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis","volume":"397","author":"Teng","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.10.006_bb0535","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2147\/DDDT.S50995","article-title":"Can the anti-inflammatory activities of beta2-agonists be harnessed in the clinical setting?","volume":"7","author":"Theron","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.nbd.2015.10.006_bb0540","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmg.2010.080366","article-title":"Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design","volume":"47","author":"Tiziano","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2015.10.006_bb0545","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cortex.2011.02.004","article-title":"The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction","volume":"48","author":"Tsermentseli","year":"2012","journal-title":"Cortex"},{"key":"10.1016\/j.nbd.2015.10.006_bb0550","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.10.006_bb0555","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/01.WNL.0000134660.30793.1F","article-title":"Strength training and albuterol in facioscapulohumeral muscular dystrophy","volume":"63","author":"van der Kooi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.10.006_bb0560","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-5728(94)00153-F","article-title":"Beta-adrenergic agonists suppress chronic\/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats","volume":"56","author":"Wiegmann","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0565","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.112.191528","article-title":"The beta2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis","volume":"342","author":"Wills","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2015.10.006_bb0570","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/ncomms2303","article-title":"A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology","volume":"3","author":"Yamashita","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2015.10.006_bb0575","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/exnr.1999.7146","article-title":"Clenbuterol, a beta(2)-adrenoceptor agonist, improves locomotor and histological outcomes after spinal cord contusion in rats","volume":"159","author":"Zeman","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0580","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.expneurol.2004.03.006","article-title":"Clenbuterol retards loss of motor function in motor neuron degeneration mice","volume":"187","author":"Zeman","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0585","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","article-title":"Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis","volume":"8","author":"Zhao","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2015.10.006_bb0590","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1101\/lm.030411.113","article-title":"Activation of beta2-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of rats","volume":"20","author":"Zhou","year":"2013","journal-title":"Learn. Mem."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611530067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611530067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T01:55:09Z","timestamp":1748656509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611530067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":119,"alternative-id":["S096999611530067X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.10.006","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b22-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}